SavedAdd your journal

Journals / Klinik Psikofarmakoloji Bülteni / 2012 / Cilt: 22 - Sayı: 3

Low dose duloxetine induced hyponatremia in an elderly patient: A case report

Yaşlı bir hastada düşük doz duloksetinin oluşturduğu hiponatremi

İlhan KORKMAZ
Salih GENCOĞLAN
Leyla AKGÜC
İnan BEYDİLLİ
Zehra UYSAL
Fevzi YILMAZ
Pages
283–285
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Whereas our case was using duloxetine low dose (30mg /day).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Duloxetine is serotonin-norepinephrine reuptake inhibitor used for major depressive disorder, stress, urinary incontinence, pain associated with diabetic neuropathy and fibromyalgia.
📊
Key Findings & Data:Nausea, dry mouth, fatigue, dizziness, decreased appetite, constipation and insomnia are the frequently reported advers effects.
💡
Conclusion & Impact:Whereas our case was using duloxetine low dose (30mg /day).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Duloxetine is serotonin-norepinephrine reuptake inhibitor used for major depressive disorder, stress, urinary incontinence, pain associated with diabetic neuropathy and fibromyalgia. Nausea, dry mouth, fatigue, dizziness, decreased appetite, constipation and insomnia are the frequently reported advers effects. Duloxetine induced hyponatremia is a rare advers effect and is seen generally among the older female patients, like our case. Whereas our case was using duloxetine low dose (30mg /day).

Özet

Duloksetin serotonin-norepinefrin gerialım inhibitörü olup major depresyonda, stres durumlarında, idrar inkontinansında ve diyabetik nöropati veya fibromyaljiye bağlı ağrı durumlarında kullanılır. Bulantı, ağız kuruluğu, halsizlik, iştahsızlık, konstipasyon ve uykusuzluk en çok bildirilen yan etkilerdir. Duloksetine bağlı hiponatremi bizim vakamızda olduğu gibi yaşlı kadınlarda nadiren görülen bir yan etkidir. Fakat bizim vakamızıfarklı kılan hasta duloksetin 30 mg/ gün kullanıyorkenhiponatremi görülmesiydi.

🔖

Cite This Article

KORKMAZ, İ., GENCOĞLAN, S., AKGÜC, L., BEYDİLLİ, İ., UYSAL, Z., YILMAZ, F. (2022). Low dose duloxetine induced hyponatremia in an elderly patient: A case report. Klinik Psikofarmakoloji Bülteni, Cilt: 22 - Sayı: 3, 283–285. https://ajindex.com/articles/574122

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Acharya N, Rosen AS, Polzer JP, D’Souza DN, Perahia DG, Cavazzoni PA et al. Duloxetine: meta-analyses of suicidal behaviors and ideation in clinical trials for major depressive disorder. J Clin Psychopharmacol 2006;26(6):587-94
  2. Preskorn SH, Greenblatt DJ, Flockhart D, Luo Y, Perloff ES, Harmatz JS et al. Comparison of duloxetine, escitalopram, and sertraline effects on cytochrome P450 2D6 function in healthy volunteers. J Clin Psychopharmacol 2007;27(1):28-34
  3. Perahia DG, Kajdasz DK, Walker DJ, Raskin J, Tylee A. Duloxetine 60 mg once daily in the treatment of milder major depressive disorder. Int J Clin Pract 2006;60(5):613-20
  4. Müssig K, Mörike K, Häring HU. Severe and symptomatic hyponatremia following duloxetine treatment. J Psychopharmacol 2009;23(3):338-9
  5. Kirby D, Harrigan S, Ames D. Hyponatraemia in elderly psychiatric patients treated with Selective Serotonin Reuptake Inhibitors and venlafaxine: a retrospective controlled study in an inpatient unit. Int J Geriatr Psychiatry 2002;17(3):231-7
  6. Stahl SM. Temel psikofarmakoloji ilaç rehberi. Direk N.(Çeviren
  7. Baskı, İstanbul: Nobel tıp kitabevi,2008,p.101. (Turkish) 7.Calabrase F, Molteni R, Maj PF. Chronic duloxetine Treatment induces specific changes in the expression of BDNF transcripts and in the subcellular localization of the neurotrophin Protein. Neuropsychopharmacology 2007;32(11):2351-9
  8. Safdieh JE, Rudominer R. A case of hyponatremia induced by duloxetine. J Clin Psychopharmacol 2006;26(6):675-6
  9. Jacob S, Spinler SA. Hyponatremia associated with selective Serotonin-reuptake inhibitors in older adults. Ann Pharmacother 2006;40: 1618-22
  10. Krüger S, Lindstaedt M. Duloxetine and hyponatremia: a report of 5 cases. J Clin Psychopharmacol 2007;27(1):101-4. 11.Lam YW. Duloxetine and a case of hyponatremia. The brown university geriatric psychopharmacology update. 2007;11(3):2-3 12.Detke MJ, Lu Y, Goldstein DJ, Hayes JR, Demitrack MA. Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial. J Clin Psychiatry 2002;63(4):308-15
  11. Goldstein DJ, Mallinckrodt C, Lu Y, Demitrack MA. Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial. J Clin Psychiatry 2002;63(3):225-31
  12. Goldstein DJ, David J, Lu Y, Detke MJ, Wiltse C, Mallinckrodt C, Demitrack MA. Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine. J Clin Psychopharmacol 2004;